• Explore /
  • Poster
  • / Correlation between time to PSA progression (TTPP), radiographic progression-free survival (rPFS) and overall survival (OS) in first-line abiraterone/enzalutamide (Abi/Enza) and docetaxel (Doc) treated patients in a prospective cohort study.

Correlation between time to PSA progression (TTPP), radiographic progression-free survival (rPFS) and overall survival (OS) in first-line abiraterone/enzalutamide (Abi/Enza) and docetaxel (Doc) treated patients in a prospective cohort study.

Abstract Poster

Authors

null

David Lorente

MEdical Oncology Department, Hospital Provincial de Castellón, Castellón De La Plana, Spain

David Lorente , Elena Castro , Rebeca Lozano , Javier Puente , Nuria Romero-Laorden , Rafael Morales-Barrera , Alejo Rodriguez Vida , M Isabel Sáez , Maria Jose Mendez-Vidal , Eva Fernandez , Elena Almagro , Amaia Hernandez , Susana Hernando Polo , Begoña Pérez-Valderrama , Fernando López-Campos , Casilda Llacer Perez , A. Montesa , Nuria Lainez , Josep M. Piulats , David Olmos

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer,Prostate Cancer

Sub Track

Prostate Cancer - Advanced Disease

Clinical Trial Registration Number

NCT03075735

Citation

J Clin Oncol 37, 2019 (suppl 7S; abstr 267)

DOI

10.1200/JCO.2019.37.7_suppl.267

Abstract #

267

Poster Bd #

M2

Abstract Disclosures

Similar Posters

First Author: Maria Jose Mendez-Vidal

First Author: Rebeca Lozano

First Author: Shingo Hatakeyama

First Author: Emily Nash Smyth